JP2011500036A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500036A5
JP2011500036A5 JP2010529193A JP2010529193A JP2011500036A5 JP 2011500036 A5 JP2011500036 A5 JP 2011500036A5 JP 2010529193 A JP2010529193 A JP 2010529193A JP 2010529193 A JP2010529193 A JP 2010529193A JP 2011500036 A5 JP2011500036 A5 JP 2011500036A5
Authority
JP
Japan
Prior art keywords
codon
cell
amino acid
construct
query
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010529193A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500036A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2008/001465 external-priority patent/WO2009049351A1/en
Publication of JP2011500036A publication Critical patent/JP2011500036A/ja
Publication of JP2011500036A5 publication Critical patent/JP2011500036A5/ja
Pending legal-status Critical Current

Links

JP2010529193A 2007-10-15 2008-10-02 構築物系およびその使用 Pending JP2011500036A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98014507P 2007-10-15 2007-10-15
PCT/AU2008/001465 WO2009049351A1 (en) 2007-10-15 2008-10-02 Construct system and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014147453A Division JP2014221068A (ja) 2007-10-15 2014-07-18 構築物系およびその使用

Publications (2)

Publication Number Publication Date
JP2011500036A JP2011500036A (ja) 2011-01-06
JP2011500036A5 true JP2011500036A5 (https=) 2011-11-17

Family

ID=40566909

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010529193A Pending JP2011500036A (ja) 2007-10-15 2008-10-02 構築物系およびその使用
JP2010529192A Active JP5543921B2 (ja) 2007-10-15 2008-10-02 免疫応答をモジュレートするための発現系
JP2014097256A Active JP6155223B2 (ja) 2007-10-15 2014-05-09 免疫応答をモジュレートするための発現系
JP2014147453A Pending JP2014221068A (ja) 2007-10-15 2014-07-18 構築物系およびその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2010529192A Active JP5543921B2 (ja) 2007-10-15 2008-10-02 免疫応答をモジュレートするための発現系
JP2014097256A Active JP6155223B2 (ja) 2007-10-15 2014-05-09 免疫応答をモジュレートするための発現系
JP2014147453A Pending JP2014221068A (ja) 2007-10-15 2014-07-18 構築物系およびその使用

Country Status (7)

Country Link
US (3) US9593340B2 (https=)
EP (2) EP2215269B1 (https=)
JP (4) JP2011500036A (https=)
AU (2) AU2008314486B2 (https=)
DK (1) DK2215269T3 (https=)
ES (1) ES2662030T3 (https=)
WO (2) WO2009049350A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101621100B1 (ko) 2007-03-30 2016-05-13 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 백신에 유용한 약독화 바이러스
JP2011500036A (ja) 2007-10-15 2011-01-06 ザ ユニバーシティー オブ クイーンズランド 構築物系およびその使用
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US9795658B2 (en) 2010-04-20 2017-10-24 Admedus Vaccines Pty Ltd Expression system for modulating an immune response
EP4015523A1 (en) 2010-05-05 2022-06-22 New York University Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
JP2014527799A (ja) 2011-08-26 2014-10-23 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
US9918724B2 (en) 2012-12-27 2018-03-20 Wright Medical Technology, Inc. Ankle replacement system and method
WO2014150841A2 (en) * 2013-03-15 2014-09-25 Dow Corning Corporation Powdered resin linear organopolysiloxane compositions
WO2015054639A1 (en) * 2013-10-11 2015-04-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Epstein-barr virus vaccines
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
AU2015327767A1 (en) * 2014-10-01 2017-04-20 Jingang Medicine (Australia) Pty Ltd Therapeutic compositions and methods for inducing an immune response to herpes simplex virus type 2 (HSV-2)
WO2016086988A1 (en) * 2014-12-03 2016-06-09 Wageningen Universiteit Optimisation of coding sequence for functional protein expression
JP2018517708A (ja) 2015-06-05 2018-07-05 ニューヨーク・ユニバーシティ 抗ブドウ球菌生物学的薬剤のための組成物及び方法
US10724040B2 (en) 2015-07-15 2020-07-28 The Penn State Research Foundation mRNA sequences to control co-translational folding of proteins
RU2744193C2 (ru) 2015-10-16 2021-03-03 Канзас Стейт Юниверсити Рисерч Фаундейшн Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
WO2017096432A1 (en) * 2015-12-09 2017-06-15 Admedus Vaccines Pty Ltd Immunomodulating composition for treatment
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
WO2019084310A1 (en) 2017-10-25 2019-05-02 Yoshihiro Kawaoka HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
MX2020014243A (es) 2018-06-19 2021-05-12 Biontech Us Inc Neoantigenos y usos de los mismos.
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
JP7655849B2 (ja) * 2018-08-20 2025-04-02 ウィスコンシン アルムニ リサーチ ファンデイション ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
EP3921413A1 (en) 2019-02-08 2021-12-15 Wisconsin Alumni Research Foundation (WARF) Humanized cell line
CN114222579A (zh) 2019-04-04 2022-03-22 勃林格殷格翰动物保健美国有限公司 猪圆环病毒3型（pcv3）疫苗及其生产和用途
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
JP2023511444A (ja) 2020-01-24 2023-03-17 ウィスコンシン アルムニ リサーチ ファンデイション 安定化されたｎａを有する組換えインフルエンザウイルス
CN111363008B (zh) * 2020-03-18 2021-11-16 北京鼎成肽源生物技术有限公司 一种输卵管癌靶标抗原组合、输卵管癌靶标抗原组合刺激培养的ctl细胞及其应用
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN115704012A (zh) * 2021-08-12 2023-02-17 中国科学院深圳先进技术研究院 一种含有降解决定子的重组病毒及其制备方法和应用
CN117448254B (zh) * 2023-10-23 2024-04-09 广州梵之容化妆品有限公司 一种光果甘草干细胞的制备方法及用途
CN120060262B (zh) * 2025-04-25 2025-08-12 中国农业科学院茶叶研究所 茶树CsU3启动子及其应用

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4184917A (en) * 1974-04-01 1980-01-22 Sandoz Ltd. Process for producing a structurally modified interferon
US4321365A (en) * 1977-10-19 1982-03-23 Research Corporation Oligonucleotides useful as adaptors in DNA cloning, adapted DNA molecules, and methods of preparing adaptors and adapted molecules
US4293652A (en) * 1979-05-25 1981-10-06 Cetus Corporation Method for synthesizing DNA sequentially
US4351901A (en) * 1980-03-24 1982-09-28 Cetus Corporation Method for single nucleotide alteration
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
US5093242A (en) * 1986-10-02 1992-03-03 Massachusetts Institute Of Technology Methods of generating desired amino-terminal residues in proteins
US4790824A (en) * 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5273876A (en) * 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
DE10399032I1 (de) 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
JPH04503306A (ja) * 1989-02-01 1992-06-18 ザ・ジェネラル・ホスピタル・コーポレーション 単純ヘルペスウイルス１型発現ベクター
CA2489769A1 (en) 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
DE3909710A1 (de) * 1989-03-23 1990-09-27 Boehringer Mannheim Gmbh Verfahren zur expression eines rekombinanten gens
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5312335A (en) * 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) * 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
ES2113371T3 (es) 1989-11-16 1998-05-01 Univ Duke Transformacion de celulas epidermicas de tejidos animales con la ayuda de particulas.
FR2658432B1 (fr) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
US5122463A (en) * 1990-05-17 1992-06-16 Massachusetts Institute Of Technology Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor
MY109299A (en) 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
EP0854193A1 (en) 1990-09-21 1998-07-22 Chiron Corporation Human retroviral packaging cell line
DE69131908T3 (de) 1991-02-19 2008-04-03 Oxford Biomedica (Uk) Ltd. Viruspartikel mit veraendertem wirtspektrum
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
WO1993019660A1 (en) * 1992-04-03 1993-10-14 Baylor College Of Medicine Gene therapy using the intestine
US5383851A (en) * 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5831005A (en) * 1992-09-24 1998-11-03 Chiron Corporation Synthesis of N-substituted oligomers
US5674703A (en) * 1992-12-02 1997-10-07 Woo; Savio L. C. Episomal vector systems and related methods
US5654186A (en) * 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
AU680508B2 (en) * 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors
US6133028A (en) * 1993-05-28 2000-10-17 Transgene S.A. Defective adenoviruses and corresponding complementation lines
US6140087A (en) * 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
US6120764A (en) * 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
US5834441A (en) 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
JPH07105638A (ja) * 1993-10-05 1995-04-21 Matsushita Electric Ind Co Ltd 画像データの記録再生装置
EP0728202A4 (en) * 1993-11-12 1997-04-23 Univ Case Western Reserve EPISOMIC EXPRESSION VECTOR FOR HUMAN GENE THERAPY
DK0690732T3 (da) * 1994-01-21 2003-05-19 Powderject Vaccines Inc Gasdrevet genindførselsinstrument
CA2117668C (en) * 1994-03-09 2005-08-09 Izumu Saito Recombinant adenovirus and process for producing the same
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5604090A (en) * 1994-06-06 1997-02-18 Fred Hutchinson Cancer Research Center Method for increasing transduction of cells by adeno-associated virus vectors
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5786464C1 (en) * 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
US5693508A (en) * 1994-11-08 1997-12-02 Chang; Lung-Ji Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
AU4594996A (en) 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
JP3770333B2 (ja) * 1995-03-15 2006-04-26 大日本住友製薬株式会社 組換えｄｎａウイルスおよびその製造方法
GB9506782D0 (en) * 1995-04-01 1995-05-24 British Biotech Pharm Retroviral vectors
WO1997008298A1 (en) * 1995-08-30 1997-03-06 Genzyme Corporation Chromatographic purification of adenovirus and aav
US6013516A (en) * 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
CA2247091A1 (en) * 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
US5952221A (en) * 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US6818222B1 (en) * 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US6287569B1 (en) * 1997-04-10 2001-09-11 The Regents Of The University Of California Vaccines with enhanced intracellular processing
IL132463A0 (en) 1997-05-13 2001-03-19 Univ North Carolina Lentivirus - based gene transfer vectors
US5993412A (en) * 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
US6156303A (en) * 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
EP1002091B1 (en) * 1997-07-09 2012-02-29 Coridon Pty Limited Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
AUPP807899A0 (en) * 1999-01-08 1999-02-04 University Of Queensland, The Codon utilization
WO2000000600A2 (en) 1997-09-22 2000-01-06 Chang Lung Ji Lentiviral vectors, comprising modified major donor splice sites and major packaging signals
CA2304983A1 (en) 1997-09-24 1999-04-01 The Regents Of The University Of California Non-primate lentiviral vectors and packaging systems
US7048929B1 (en) 1997-11-10 2006-05-23 Dana-Farber Cancer Institute, Inc. Stabilized primate lentivirus envelope glycoproteins
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
AU749059B2 (en) 1997-12-12 2002-06-20 Cell Genesys, Inc. Therapeutic use of lentiviral vectors
WO1999051754A1 (en) 1998-04-02 1999-10-14 Dana-Farber Cancer Institute, Inc. Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
AUPP807799A0 (en) 1999-01-08 1999-02-04 University Of Queensland, The Polynucleotide and method
DE60044125D1 (de) 1999-04-14 2010-05-20 Novartis Vaccines & Diagnostic Zusammensetzungen und verfahren zur auslösung einer immunantwort auf basis alphavirus-vektoren-systeme
ATE528406T1 (de) 1999-04-29 2011-10-15 Gbp Ip Llc Verfahren und mittel zur herstellung von sicheren,rekombinanten lentivirusvektoren mit hohem titer
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
WO2001081609A2 (en) 2000-03-22 2001-11-01 Chiron Corporation Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
CA2434546C (en) 2001-01-12 2012-09-11 Chiron Corporation Induction of immune response by a replication-defective venezuelan equine encephalitis-sindbis chimeric virus replicon particle encoding an antigen
JP4608210B2 (ja) 2001-05-31 2011-01-12 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド キメラアルファウイルスレプリコン粒子
JP2006500927A (ja) 2002-09-13 2006-01-12 ザ・ユニバーシティ・オブ・クイーンズランド コドン翻訳効率に基づく遺伝子発現系
JP2006506986A (ja) * 2002-11-08 2006-03-02 ザ ユニバーシティー オブ クイーンズランド 同義コドンの最適化を用いて遺伝子発現を最適化するための方法
CA2658484A1 (en) * 2006-07-20 2008-01-24 Vical Incorporated Compositions and methods for vaccinating against hsv-2
JP2011500036A (ja) 2007-10-15 2011-01-06 ザ ユニバーシティー オブ クイーンズランド 構築物系およびその使用
US9795658B2 (en) * 2010-04-20 2017-10-24 Admedus Vaccines Pty Ltd Expression system for modulating an immune response

Similar Documents

Publication Publication Date Title
JP2011500036A5 (https=)
Kal et al. Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources
Whyte et al. Vesicle tethering complexes in membrane traffic
Palmieri et al. Evolution, structure and function of mitochondrial carriers: a review with new insights
Vollmeister et al. Fungal development of the plant pathogen Ustilago maydis
ATE509091T1 (de) S. pastorianus ssu1-gen, polypeptid, und ihre verwendung zur herstellung von alkohol
EA201170506A1 (ru) Генная терапия порфобилиногендезаминазой
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
ATE528403T1 (de) Verfahren zur herstellung von ungesättigten omega-3-fettsäuren in transgenen organismen
EP2857515A3 (en) Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
WO2002068605A3 (en) Non-oligomerizing tandem fluorescent proteins
RU99107670A (ru) Высокопродуктивная экспрессия белков
EA201070371A1 (ru) Axmi-066 и axmi-076: дельта-эндотоксиновые белки и способы их применения
DE60227937D1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen aus der familie der enterobacteriacea die ein attenuiertes dgsa-gen enthalten
JP2018500009A5 (https=)
RU2010103255A (ru) Гены и способы обеспечения устойчивости к фитофторозу пасленовых
RU2008134484A (ru) Новые флуоресцентные белки и способы их применения
WO2006053021A3 (en) Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby
DE60122562D1 (de) Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
RU2008148140A (ru) Синтетаза жирных кислот, кодирующий ее полинуклеотид и их применение
WO2011083344A3 (en) Antimicrobial peptides
Richter et al. Interacting bactofilins impact cell shape of the MreB-less multicellular Rhodomicrobium vannielii
WO2015077447A3 (en) Nucleotide sequence encoding wuschel-related homeobox4 (wox4) protein from corchorus olitorius and corchorus capsularis and methods of use for same
ATE522543T1 (de) Verfahren zur herstellung von reifem, rekombinantem milben-i-allergen
Huang et al. Pangenome analysis reveals structural variations associated with citric acid accumulation in Prunus mume